I4V-MC-KHAA - ClinicalTrials.gov - NCT04421027
I4V-MC-KHAA - ClinicalTrials.gov - NCT04421027
Key Requirements
Key Requirements
Use the following checklist to help determine if this trial may be a good fit for you. Place a checkmark next to each criteria that you successfully meet.
Participants must
Be hospitalized with coronavirus (SARS-COV-2)
Need oxygen therapy when they enter the study and when assigned to treatment
Participants must NOT
Have ever received convalescent plasma or intravenous immunoglobulin [IVIg]) for COVID-19
Have received greater than 20 milligrams per day of oral corticosteroids for more than 14 days before study start
Have received antibodies that block the COVID-19 virus
Have active tuberculosis (TB)
Have an active infection (besides COVID-19)
Require a ventilator at study entry
Have cancer
Have a history of more than one blood clot or a blood clot within 12 weeks before entering study
Be pregnant or breastfeeding
Trial Summary
Conditions the trial is for
COVID-19 (Coronavirus)
What the trial is testing?
Baricitinib
Could I receive a Placebo?
yes
Enrollment Goal
1400
Trial Dates
September 2019 - June 2021
Trial Phase
3
Key Requirements
Use the following checklist to help determine if this trial may be a good fit for you. Place a checkmark next to each criteria that you successfully meet.
Participants must
Be hospitalized with coronavirus (SARS-COV-2)
Need oxygen therapy when they enter the study and when assigned to treatment
Participants must NOT
Have ever received convalescent plasma or intravenous immunoglobulin [IVIg]) for COVID-19
Have received greater than 20 milligrams per day of oral corticosteroids for more than 14 days before study start
Have received antibodies that block the COVID-19 virus
Have active tuberculosis (TB)
Have an active infection (besides COVID-19)
Require a ventilator at study entry
Have cancer
Have a history of more than one blood clot or a blood clot within 12 weeks before entering study
Be pregnant or breastfeeding
Trial Summary
Conditions the trial is for
COVID-19 (Coronavirus)
What the trial is testing?
Baricitinib
Could I receive a Placebo?
yes
Enrollment Goal
1400
Trial Dates
September 2019 - June 2021
Trial Phase
3
Trial Locations
Hide locations not currently recruiting